Related references
Note: Only part of the references are listed.MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway
Qinghua Fu et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Ginsenoside Rg3 suppresses the NLRP3 inflammasome activation through inhibition of its assembly
Yuhua Shi et al.
FASEB JOURNAL (2020)
Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury
Lan Li et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Roles of ginsenosides in inflammasome activation
Young-Su Yi
JOURNAL OF GINSENG RESEARCH (2019)
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Melatonin differentially regulates pathological and physiological cardiac hypertrophy: Crucial role of circadian nuclear receptor RORα signaling
Longwei Xu et al.
JOURNAL OF PINEAL RESEARCH (2019)
A new role for the ginsenoside RG3 in antiaging via mitochondria function in ultraviolet-irradiated human dermal fibroblasts
Hyunji Lee et al.
JOURNAL OF GINSENG RESEARCH (2019)
Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro
Ningning Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis
Xi-Chun Pan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ginsenoside-Rb2 and 20(S)-Ginsenoside-Rg3 from Korean Red Ginseng Prevent Rotavirus Infection in Newborn Mice
Hui Yang et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure
Li Jin et al.
SCIENTIFIC REPORTS (2018)
Effects of Ginsenoside Rg3 on fatigue resistance and SIRT1 in aged rats
Qi-Yu Yang et al.
TOXICOLOGY (2018)
Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats
Qiu Huiliang et al.
PHYTOMEDICINE (2018)
Anticancer effects of ginsenoside Rg3 (Review)
Mengyao Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Suppressive Effect of Ginsenoside Rg3 against Lipopolysaccharide-Induced Depression-Like Behavior and Neuroinflammation in Mice
An Kang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling
Leonardo Schirone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Ginsenoside Rg3 inhibits the senescence of prostate stromal cells through down-regulation of interleukin 8 expression
Yanfei Peng et al.
ONCOTARGET (2017)
Ginsenoside Rg3 attenuates sepsis-induced injury and mitochondrial dysfunction in liver via AMPK-mediated autophagy flux
Wei Xing et al.
BIOSCIENCE REPORTS (2017)
Ginsenoside Rg3 Improves Cardiac Function after Myocardial Ischemia/Reperfusion via Attenuating Apoptosis and Inflammation
Li-ping Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Netrin-1 prevents the development of cardiac hypertrophy and heart failure
Nan Wang et al.
MOLECULAR MEDICINE REPORTS (2016)
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
Yow Keat Tham et al.
ARCHIVES OF TOXICOLOGY (2015)
Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS
Sung-Jin Yoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor 1
Rokhsana Mortuza et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt
Xiaoying Wang et al.
PHYTOMEDICINE (2015)
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways
Gang Chen et al.
ACTA PHARMACOLOGICA SINICA (2014)
Regulation of Akt Signaling by Sirtuins Its Implication in Cardiac Hypertrophy and Aging
Vinodkumar B. Pillai et al.
CIRCULATION RESEARCH (2014)
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders
Anu Kauppinen et al.
CELLULAR SIGNALLING (2013)
Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism
Liangzhu Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
The Ginsenoside Rg1 Prevents Transverse Aortic Constriction-Induced Left Ventricular Hypertrophy and Cardiac Dysfunction by Inhibiting Fibrosis and Enhancing Angiogenesis
Yao-Jun Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation
Ana Planavila et al.
CARDIOVASCULAR RESEARCH (2011)
Interrelationship Between Cardiac Hypertrophy, Heart Failure, and Chronic Kidney Disease Endoplasmic Reticulum Stress As a Mediator of Pathogenesis
Jeffrey G. Dickhout et al.
CIRCULATION RESEARCH (2011)
Angiotensin II and cell cycle regulation
G Wolf et al.
HYPERTENSION (2004)